What is tocilizumab?
Tocilizumab is a monoclonal antibody that is approved for the treatment of Giant Cell Arteritis (GCA).
How does tocilizumab work?
Tocilizumab works by blocking IL-6. IL-6 is an immune system protein that promotes inflammation.
How is tocilizumab given?
Tocilizumab can be self-administered as an injection (weekly or every 2 weeks) or given intravenously at an infusion center (monthly).
We pay particular attention to liver function tests, lipids, and blood counts when using tocilizumab.
All immunosuppressants require regular monitoring in the form of blood tests, in-person assessments, and prompt attention to any signs or symptoms of infection.